Javascript must be enabled to continue!
Immunohistochemical expression of p53, ki-67, tenascin, and fibronectin in giant cell fibroma and traumatic fibroma of the oral mucosa
View through CrossRef
Objective: This study aimed to compare the immunoexpression of p53, ki-67, tenascin, and fibronectin between giant cell fibroma (GCF) and traumatic fibroma (TF), in order to explore a benign neoplastic or a reactive nature of GCF.
Methods: A cross-sectional study was conducted. Samples of GCF and TF were retrieved from the files of Oral Pathology Service, matched by site and size. Immunohistochemistry for p53, ki-67, tenascin, and fibronectin was evaluated in the superficial and deep regions of the lesions using the Image J Software. The number of positive cells was determined for p53 and ki-67, and the positive area was established for tenascin and fibronectin. Statistical analysis was performed with Mann-Whitney and independent t-tests (p≤0.05).
Results: Comparing to TF, GCF showed higher expression of p53 protein in superficial (p=0.009) and deep regions (p=0.027), as well as higher tenascin expression in deep regions (p=0.000). Ki-67 and fibronectin immunoexpression did not differ between GCF and TF (p>0.05).
Conclusions: The results of the present study seem supportive of a benign neoplastic nature of GCF, rather than a reactive one, especially considering the p53 and tenascin expression. Further studies with larger samples and broader markers should confirm this hypothesis.
Title: Immunohistochemical expression of p53, ki-67, tenascin, and fibronectin in giant cell fibroma and traumatic fibroma of the oral mucosa
Description:
Objective: This study aimed to compare the immunoexpression of p53, ki-67, tenascin, and fibronectin between giant cell fibroma (GCF) and traumatic fibroma (TF), in order to explore a benign neoplastic or a reactive nature of GCF.
Methods: A cross-sectional study was conducted.
Samples of GCF and TF were retrieved from the files of Oral Pathology Service, matched by site and size.
Immunohistochemistry for p53, ki-67, tenascin, and fibronectin was evaluated in the superficial and deep regions of the lesions using the Image J Software.
The number of positive cells was determined for p53 and ki-67, and the positive area was established for tenascin and fibronectin.
Statistical analysis was performed with Mann-Whitney and independent t-tests (p≤0.
05).
Results: Comparing to TF, GCF showed higher expression of p53 protein in superficial (p=0.
009) and deep regions (p=0.
027), as well as higher tenascin expression in deep regions (p=0.
000).
Ki-67 and fibronectin immunoexpression did not differ between GCF and TF (p>0.
05).
Conclusions: The results of the present study seem supportive of a benign neoplastic nature of GCF, rather than a reactive one, especially considering the p53 and tenascin expression.
Further studies with larger samples and broader markers should confirm this hypothesis.
Related Results
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract
Although the main function of p53 is a nuclear transcription factor that has important roles in cell cycle arrest, DNA repair, and apoptosis, p53 can direct...
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has ...
Data from Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
Data from Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
<div>Abstract<p><b>Purpose:</b> Seventy to eighty percent of rhabdomyosarcoma (RMS) tumors retain wild-type p53. The tumor suppressor p53 plays a central ro...
Data from Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
Data from Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
<div>Abstract<p><b>Purpose:</b> Seventy to eighty percent of rhabdomyosarcoma (RMS) tumors retain wild-type p53. The tumor suppressor p53 plays a central ro...
STK4 antisense RNA 1-p53 affects osteosarcoma
STK4 antisense RNA 1-p53 affects osteosarcoma
Abstract
Background
LncRNA STK4 antisense RNA 1(STK4-AS1) has been identified as a potential biomarker associated with multiple cancers. We proposed that STK4-AS1 plays a ...
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Abstract
Background
The mechanisms that can restore biological activity of mutant p53 are an area of high interest given that mutant p53 expressi...
Abstract 1716: A small molecule corrector for p53 mutants found in cancer
Abstract 1716: A small molecule corrector for p53 mutants found in cancer
Abstract
p53 is the main tumor suppressor protein in vertebrates and the most frequently mutated gene in human cancers. The majority of p53 mutations are missense mu...


